Current Opinion in Oncology

Article	Citations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	64
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	46
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	42
Role of PSMA PET/CT in imaging and management of prostate cancer	36
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	31
Treatments and challenges in advanced prostate cancer	29
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	24
Editorial introductions	24
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	22
Harnessing dendritic cells for innovative therapeutic cancer vaccines	21
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	21
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	20
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	20
Psycho-oncology interventions focusing on fatigue and sleep disturbances	18
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	17
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	17
Biomarkers and immunotherapy: where are we?	16
Indications and technique of minimally invasive surgery in early-stage cervical cancer	15
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	14
Editorial introductions	14
New hopes in relapsed refractory primary central nervous system lymphoma	13
Editorial introductions	13
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	13
Safety of assisted reproductive techniques in gynecological cancer patients	13
Neoadjuvant and adjuvant approaches in gastroesophageal cancers	13

Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	13
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	12
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	12
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	12
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	12
How to prevent human papillomavirus-related oropharyngeal cancer?	12
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	11
Circulating tumor DNA in breast cancer: a biomarker for patient selection	11
Immunomodulation for hepatocellular carcinoma therapy: current challenges	11
Liquid biopsy in brain tumors: moving on, slowly	11
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights	11
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	11
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	11
Editorial introductions	10
Recent advances in precision medicine for acute myeloid leukemia	10
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	10
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	10
Editorial: Lung cancer: continuous progress in diagnosis and treatment	10
Editorial introductions	10
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	9
Lung cancer screening in never smokers	9
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	9
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	9
Pathology and new insights in central nervous system lymphomas	9
Machine learning applications and challenges in graft-versus-host disease: a scoping review	9
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	9
The 5T's of health disparities in multiple myeloma in Latin America	9
Desmoid tumors: who, when and how to treat?	9
A new comprehensive and stratified concept for supportive care in cancer patients	8
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	8
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	8
The changing landscape for patients with relapsed/refractory acute myeloid leukaemia	8
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	8
The role of genetic testing in prostate cancer screening, diagnosis, and treatment	8
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	8
Editorial introductions	8
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	8
Editorial introductions	7
How to support parenting in patients with cancer and co-parents? From research to practice	7
Current role and indications of minimally invasive surgery in gynecologic oncology	7
Pathologic diagnosis of lung cancer – recent developments	7
Editorial introductions	7
Advantages of robotic surgery in obese patients with endometrial cancer	7
Editorial introductions	7
Application of single-port techniques in endometrial cancer	7
Mind the target: programmed death ligand 1 in oesophagogastric cancers	7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	7
Potential application of artificial intelligence in cancer therapy	7
Preclinical glioma models in neuro-oncology: enhancing translational research	6
Adjuvant and neoadjuvant approaches in pancreatic cancer	6

When do I ask for a DNA methylation array for primary brain tumor diagnosis?	6
Cellular therapies in sarcoma and other solid tumors	6
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	6
Targeting cancer stem cell pathways for lung cancer therapy	6
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	6
Editorial introductions	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	6
How to monitor the side effects of treatments in cancer patients	6
Breast surgery after neoadjuvant therapy	6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	6
Immunotherapies in non-metastatic gastrointestinal cancers	6
Question prompt lists to improve communication between cancer patients and healthcare professionals	6
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	6
Treatment of radiation-associated angiosarcoma	6
Editorial introductions	6
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	5
Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?	5
Polyamine metabolism in prostate cancer	5
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	5
Richter transformation: biological insights, diagnostic challenges and emerging therapies	5
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	5
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas	5
Update on bi-specific monoclonal antibodies for blood cancers	5
Preoperative immunotherapy for head and neck cancers: state of art	5
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	5
Achievements of international rare cancers networks and consortia in the neuro-oncology field	5
HIV-related lymphomas	5
How to treat localized Hodgkin lymphoma?	5
Immunotherapy of sarcomas with modified T cells	5
Endoscopic inguinal lymphadenectomy for vulvar cancer, is it feasible?	5
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	5
Clinical management of brain tumors in pregnancy	5
Precision, personalization, and quality of life for patients with lymphoma	5
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	5
Thymic malignancies: role of immunotherapy and novel approaches	5
Early Detection of Cancers in the Era of Precision Oncology	4
High-risk smoldering myeloma – a case for early intervention?	4
Current opinion on laparoscopic surgery in gynecologic oncology: challenges and advances in elderly patients	4
Optimizing the prescription doses and tolerability of systemic therapy in head and neck cancer patients	4
How to treat advanced Hodgkin lymphoma?	4
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	4
Update of antibody–drug conjugates for hematological malignancies	4
Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?	4
Targeting exon 20 insertion mutations in lung cancer	4
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients	4
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice	4
Editorial introductions	4
Editorial: Psychological interventions in oncology: advances and challenges	4
New strategies for the treatment of breast cancer with leptomeningeal metastasis	4
Ovarian stimulation and oocyte cryopreservation in females with cancer	4
Molecular genotyping in medullary thyroid cancer	4
Perioperative immunotherapy in nonsmall cell lung cancer	4
Recent advances in immunotherapy for small cell lung cancer	4
Vascular complications in patients with brain tumors	4
Precision medicine in extended adjuvant endocrine therapy for breast cancer	4
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	4
Future of sentinel node biopsy in ovarian cancer	4
New trends in supportive care of head and neck cancers	4
Editorial introductions	4
Minimally invasive surgery in advanced and recurrent ovarian cancer: current evidence and future directions	3
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	3
CIC-DUX4 sarcomas	3
Circulating tumor DNA in B cell lymphomas	3
New treatment strategies for primary central nervous system lymphoma	3
Editorial Introductions	3
Use of staging for sex cord stromal tumours	3
Advance care planning in oncology: a scoping review and some recommendations	3
Challenges in the management of relapsed germ cell tumors	3
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	3
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	3
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	3
Recent advances in allogeneic transplantation for acute myeloid leukemia	3
Evolving systemic management of urothelial cancers	3
Postneoadjuvant treatment for triple-negative breast cancer	3
Action against thoracic cancers: recent achievements and perspectives	3
Management of epilepsy in brain tumor patients	3
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	3
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?	3
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	3

Advances in testing for human papillomavirus-mediated head and neck cancer	3
Highlights of recent research focused on the treatment of advanced prostate cancer	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Editorial introductions	3
Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy	3
New treatments for desmoid tumors	3
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
New targeted treatments for advanced sarcomas	3
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	3
Perioperative immunotherapy for nonsmall cell lung cancer	3
Emerging therapies in Ewing sarcoma	3
Cancer-associated thrombosis: what is new?	3
Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019–2021	3
Unveiling the role of cellular dormancy in cancer progression and recurrence	3
The role of next-generation sequencing in acute myeloid leukemia	3
Treatment of small cell lung cancer: recent advances	3
Editorial: Advanced care planning	3
Advances in the treatment of light chain amyloidosis	3
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine	2
A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword?	2
Artificial intelligence: opportunities in lung cancer	2
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities	2
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?	2
Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA	2
Immuno-oncology in the daily practice	2
Chemotherapy-induced nausea and vomiting: can we do better?	2
Resistance mechanisms to osimertinib and emerging therapeutic strategies in nonsmall cell lung cancer	2
Surrogate endpoints for HTA decisions of breast cancer drugs: utility and pitfalls	2
Medical treatment of angiosarcomas	2
The role of menin inhibitors in acute myeloid leukemia	2
Editorial: ’All you need is immunotherapy’: a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?	2
Editorial: Advances in cancer detection and diagnosis: from liquid biopsies and molecular biomarkers to opportunistic intratumoral bacteria	2
Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer	2
First line treatments in primary central nervous system lymphomas in young patients	2
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	2
Interventions for children of parents with cancer: an overview	2
The potential roles of antibody-drug conjugates in head and neck squamous cell carcinoma	2
Implementation of sentinel node biopsy in high-risk endometrial cancer	2
Primary central nervous system lymphoma (PCNSL) in older patients	2
Editorial introductions	2
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives	2
Recent advances in primary resistance mechanisms against immune checkpoint inhibitors	2
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy	2
Sarculator: how to improve further prognostication of all sarcomas	2
Active surveillance in favorable intermediate risk prostate cancer: outstanding questions and controversies	2
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA	2
Editorial: Less is more in gynaecological oncology: paving the way for the future	2
Treatment approaches for older Hodgkin lymphoma patients	2
Active surveillance and emerging medical treatment options for desmoid: when and for whom?	2
Immune checkpoint inhibitors in elderly patients with lung cancer: evidence from phase 3 trials	2
Postmastectomy radiotherapy: a review	2